Q13490 (BIRC2_HUMAN) Homo sapiens (Human)
Baculoviral IAP repeat-containing protein 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
28 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The BIR3 domain of cIAP1 in complex with the N terminal peptide from SMAC/DIABLO (AVPIAQ). |
Heteromer Q9NR28; | 100 | 1×ZN; | |||
| Ternary complex structure - BTK cIAP compound 15 |
Heteromer Q06187; | 100 | 1×ZN; 1×TKY; | |||
| Ternary complex structure - BTK cIAP compound 17 |
Heteromer Q06187; | 100 | 1×TL7; 1×ZN; | |||
| Structure of cIAP1, BTK and BCCov |
Heteromer Q06187; | 100 | 1×TOO; 1×ZN; | |||
| CIAP1-BIR3 in complex with N-terminal peptide from Caspase-9 (ATPFQE) |
Heteromer P55211; | 100 | 1×ZN; | |||
| Crystal structure of human BIRC2 BIR3 domain in complex with histone H3 |
Heteromer Q6NXT2; | 100 | 6×EDO; 1×ZN; | |||
| Crystal structure of cIAP1 RING domain bound to UbcH5B-Ub and a non-covalent Ub |
Heteromer P0CG47; P62837; | 100 | 2×ZN; | |||
| cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac037 | homo-4-mer | 100 | 4×SMK; 4×ZN; | |||
| cIAP1-BIR3 in complex with a divalent Smac mimetic | homo-2-mer | 100 | 2×ZN; 1×0O6; | |||
| IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization | monomer | 98.98 | 3×ZN; | |||
| Structure of cIAP1 CARD | monomer | 100 | ||||
| cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac066 | monomer | 100 | 1×ZN; 1×BMB; | |||
| Structure of cIAP1-BIR3 and inhibitor | monomer | 100 | 1×ZN; 1×436; 1×PO4; | |||
| Crystal structure of cIAP1-BIR3 in complex with a covalently bound SM | monomer | 100 | 1×ZN; 1×C3K; | |||
| SOLUTION STRUCTURE OF A BACULOVIRAL INHIBITOR OF APOPTOSIS (IAP) REPEAT | monomer | 100 | 1×ZN; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 2×SO4; 1×7H9; | |||
| Crystal structure of cIAP1 BIR3 bound to T3256336 | monomer | 100 | 1×ZN; 1×1AQ; | |||
| Crystal structure of cIAP1 BIR3 bound to T3258042 | monomer | 100 | 1×ZN; 1×2DX; | |||
| Crystal structure of cIAP1 BIR3 bound to T3170284 | monomer | 100 | 1×ZN; 1×1BG; | |||
| Structure of cIAP1 with BCCov | monomer | 100 | 1×ZN; 1×TO0; | |||
| Crystal structure of clAP1 BIR3 bound to T3261256 | monomer | 100 | 1×ZN; 1×1Y0; | |||
| Crystal structure of cIAP1 BIR3 bound to T3450325 | monomer | 100 | 1×ZN; 1×2DY; | |||
| Crystal structure of clAP1 BIR3 bound to T3226692 | monomer | 100 | 1×ZN; 1×1YH; | |||
| Structure of cIAP with compound 15 | monomer | 100 | 1×ZN; 1×TKY; | |||
| Crystal structure of human BIRC2 BIR3 domain in complex with inhibitor LCL-161 | monomer | 100 | 1×ZN; 3×EDO; 1×IUN; | |||
| Apo structure of BIR2 Domain of BIRC2 | monomer | 100 | 1×ZN; 6×EDO; | |||
| Crystal structure of cIAP1 BIR3 bound to GDC0152 | monomer | 96.97 | 2×ZN; | |||
| Structure of BIR1 from cIAP1 | monomer | 100 | 1×ZN; | |||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3t6p.1.A | monomer | 0.83 | 3×ZN; | 98.55 | ||
| 2l9m.1.A | monomer | 0.66 | 100.00 | |||
| 8fvu.1.A | monomer | 0.52 | 1×ZN; | 33.33 | ||
| 8fml.1.A | monomer | 0.51 | 28.90 | |||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3t6p.1.A | monomer | 0.84 | 3×ZN; | 98.55 | ||
| Isoform 2 | 2l9m.1.A | monomer | 0.65 | 100.00 | |||
| Isoform 2 | 8fvu.1.A | monomer | 0.54 | 1×ZN; | 33.51 | ||